What Mrm Proteomics does

MRM Proteomics Inc. is a private Canadian biotechnology company founded in 2010 as a spin-off of the University of Victoria-Genome BC Proteomics Centre, specializing in mass spectrometry-based quantitative proteomics and metabolomics. The company operates laboratories in Montreal, Canada and Rüsselsheim, Germany, serving biopharmaceutical firms, academic researchers, contract research organizations, and clinical research organizations globally. Its commercial portfolio spans standardized proteomics kits (PeptiQuant Plus for human and mouse plasma at $9,900 and $6,105 respectively, MetaboloMetrics Bile Acids at $3,850), targeted proteogenomic kits (PeptiQuant Onco), the SysQuan platform for system-wide absolute protein quantitation across 40+ tissues, and bioinformatics databases including MRMAssayDB (500K+ assays, 38K+ proteins from 72 organisms).

The company monetizes through three channels: (1) one-time/perpetual-license kit sales via direct e-commerce and an Agilent Technologies commercial partnership; (2) fee-for-service analytical work from its Canadian and European laboratories covering PeptiQuant, metabolomics, MALDI tissue imaging, top-down HDX-MS protein characterization, iMALDI clinical assay development, and custom peptide synthesis; and (3) consulting and training engagements. Proprietary technologies include SysQuan (using isotopically labeled mice as universal internal standards), top-down HDX-MS for proteins up to 150 kDa, and the patent-pending MCAEF MALDI matrix application.

MRM Proteomics holds ISO 9001 and CLIA certifications for clinical-grade metabolite and protein assays, supports its positioning with 300+ peer-reviewed publications, and is preparing 2026 co-launches with Agilent of PeptiQuant Onco and SysQuan kits at ASMS 2026 in San Diego. The company is privately held with no disclosed institutional investors, is headquartered in Montreal, and receives research support from Genome Canada and Genome Quebec.

Name

Mrm Proteomics

Legal name

MRM Proteomics Inc.

Website

https://mrmproteomics.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

MRM Proteomics Inc. is a private Canadian biotech founded in 2010 that develops mass spectrometry-based quantitative proteomics kits, metabolomics assays, and laboratory services for biopharmaceutical, academic, CRO, and clinical research clients worldwide.

Ownership category

akta.pro rank

Product category

Proteomics and Metabolomics Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Proteomics & Mass Spectrometry Services (HLAGANAB)

akta.pro secondary industries

Proteomics & Biomarker Analytical Testing (HLAGADAG), Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB), Metabolomics & Lipidomics Services (HLAGANAG), Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE), Translational Medicine & Biomarkers (HLAIALAF)

Keywords

• Targeted proteomics services
• Mass spectrometry kits
• Metabolomics analysis
• Protein characterization
• Tissue imaging services

Headquarters

HQ city

Montreal

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Kit Sales: Sale of PeptiQuant Plus Proteomics Kits for human and mouse plasma analysis, MetaboloMetrics Bile Acids kits. Customers purchase turnkey kits with internal standards, SOPs, and analysis tools for in-house LC-MS/MS operation.
2. Proteomics & Metabolomics Services: Fee-for-service laboratory analysis including PeptiQuant Services, Metabolomics Services, Protein Characterization, Tissue Imaging. Services offered from laboratories in Canada and Europe.
3. Consulting & Training: Expert consulting services to help clients establish proteomics workflows, implement custom solutions, and train team members with best practices. Site visits also available.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

MRM Proteomics sells quantitative proteomics and metabolomics kits (PeptiQuant™ Plus, PeptiQuant™ Onco, MetaboloMetrics, SysQuan™, QC kits) and provides fee-for-service laboratory analysis using MRM-MS, HDX-MS, MALDI-MS tissue imaging, and FT-ICR-MS, supported by bioinformatics databases (MRMAssayDB, PeptideTracker, MouseQuaPro). Its customers include biopharmaceutical companies, CROs, academic researchers, and clinical research organizations worldwide.

Product overview

MRM Proteomics offers a comprehensive proteomics and metabolomics portfolio comprising three product lines (PeptiQuant Plus quantitation kits, PeptiQuant Onco cancer mutation kits, and SysQuan system-wide absolute quantitation technology) alongside six service categories (PeptiQuant Services, Tissue Imaging, Protein Characterization, Metabolomics, Bioinformatics databases, and Custom Solutions). The core PeptiQuant platform uses rigorous MRM-MS with paired heavy/light peptide standards for multiplexed protein quantitation (up to 375 proteins), while SysQuan enables 10,000+ protein quantitation across 40+ tissues using isotopically labeled mouse standards. The bioinformatics suite includes MRMAssayDB, PeptideTracker, PeptidePicker Library, and MouseQuaPro for assay management and cross-species research. Services span targeted and untargeted metabolomics, MALDI-MS tissue imaging, HDX-MS structural analysis, and iMALDI clinical assay development.

Differentiator

Problem solved

Functional benefit

Brands

• SysQuan™: System-wide, tissue-specific absolute quantitation technology using isotopically labeled mice for proteome-wide quantitative analysis covering 10,000+ proteins.
• PeptiQuant™
• PeptiQuant™ Onco
• PeptiQuant™ Plus
• PeptiQuant™ Services
• PeptiQuant™ Plus Quality Control Kits
• MRMAssayDB
• MouseQuaPro
• PeptideTracker
• PeptidePicker Library
• iMALDI

Products and services

• PeptiQuant™ Plus Quantitation Kit for Human Plasma Multiplexed MRM-MS assay kit quantifying up to 270 proteins from a single human plasma sample using paired heavy/light SIS peptide standards with calibration curves; includes SOPs, instrument files, and Skyline analysis templates. Priced at $9,900.00 one-time/perpetual license.
• PeptiQuant™ Plus Quantitation Kit for Mouse Plasma Multiplexed MRM-MS assay kit for quantifying up to 375 mouse plasma proteins across 3 panels of 125 proteins each, requiring only 10 µL plasma per panel. Priced at $6,105.00 one-time/perpetual license.
• PeptiQuant™ Onco Kits Targeted proteogenomics kit translating cancer mutations into deployable quantitative protein assays, providing paired wild-type and mutant peptide assays for approximately 1,000 clinically relevant recurrent cancer variants. Commercialized with Agilent Technologies.
• PeptiQuant™ Plus Quality Control Kits Quality control kits for LC-MRM-MS/MS proteomics workflows, including Instrument Performance Kits for routine monitoring and Workflow Performance Kits for end-to-end assessment, containing isotope-labeled peptide standards across various masses and chemistries.
• MetaboloMetrics™ Bile Acids Precision Biomarker Kit Targeted metabolomics kit quantifying 47 bile acids from a single sample using rigorous MRM-MS with isotope-labeled internal standards and 47 calibration standards; validated across multiple LC-MS platforms. Priced at $3,850.00 one-time/perpetual license.
• SysQuan™ Technology / SysQuan Kits System-wide absolute protein quantitation platform using isotopically labeled mice to generate internal standards, enabling quantification of 10,000+ proteins across 40+ tissues and biofluids at significantly reduced cost versus conventional methods. Commercialized with Agilent Technologies.
• PeptiQuant™ Services Fee-for-service quantitative proteomics using PeptiQuant Plus MRM-MS with paired heavy/light peptide standards, quantifying up to 375 proteins from a single sample with Tier II CPTAC-guideline characterization for robust, reproducible measurements.
• Tissue Imaging Service MALDI-MS tissue imaging service visualizing spatial distribution of more than 600 proteins, peptides, drugs and metabolites, leveraging patent-pending MCAEF matrix technology and 12 Tesla FT-ICR-MS for high-resolution imaging.
• Protein Characterization Services Structural proteomics services using top-down HDX-MS (proteins up to 150 kDa including intact antibodies), bottom-up HDX-MS, PTM analysis, crosslinking, surface modification, and limited proteolysis for comprehensive protein structural analysis.
• Metabolomics Services Targeted metabolomics (~1,000 metabolites across 20 services) and untargeted metabolomics for discovery studies, including pathway-specific and compound-class-specific UPLC-MRM/MS methods covering amino acids, fatty acids, bile acids, steroids, and other metabolite classes.
• Peptide Synthesis Service Fmoc peptide synthesis service using in-house synthesizer, producing high-purity custom peptide standards in natural abundance, heavy-labeled, or double-labeled isotope formats for proteomics analysis.
• iMALDI Clinical Assay Development Custom clinical proteomics assay development using iMALDI technology with SIS peptides for reproducible antibody-independent quantitation, isoform discrimination, and high-throughput automation compatibility for clinical testing.
• Consulting & Training Services Expert consulting services helping clients establish proteomics workflows, implement custom solutions, and train team members on best practices, with site visits available.

Quantifiable outcome

• 10,000+ proteins quantified with SysQuan technology at 1/10th the cost of conventional methods
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core, foundational and minor.

• Agilent TechnologiescoreStrategic or Co-development PartnerStrategic partnership for commercialization of PeptiQuant Onco cancer mutation kits and SysQuan product line. Joint development of standardized mass spectrometry kits with educational support and customized services. SysQuan product line partnership since 2025.
• University of Victoria-Genome BC Proteomics CentrefoundationalStrategic or Co-development PartnerOriginal technology spin-off source. MRM Proteomics was launched in 2010 as a spin-off company to commercialize proteomics technologies, tools, and know-how developed at this center.
• Warren Y. Soper Clinical Proteomics CentreminorStrategic or Co-development PartnerAcademic partnership for clinical proteomics research collaboration.
• McGill Segal Cancer Proteomics CentreminorStrategic or Co-development PartnerAcademic partnership focused on cancer proteomics research.
• University of Manitoba, Max Rady College of MedicineminorStrategic or Co-development PartnerAcademic research partnership in medical proteomics.
• University of Iceland, Faculty of Pharmaceutical SciencesminorStrategic or Co-development PartnerAcademic partnership for pharmaceutical proteomics research.
• ISAS, Leibniz Institute for Analytical SciencesminorStrategic or Co-development PartnerAcademic partnership for analytical sciences research.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Agilent Technologies: Agilent is a strategic commercialisation partner for MRM Proteomics' PeptiQuant Onco and SysQuan product lines, and also a major manufacturer of LC-MS instruments and consumables for proteomics/metabolomics. Comparable due to the joint commercialisation relationship and overlapping customer base.
• Bruker Daltonics: Major manufacturer of mass spectrometry instrumentation including timsTOF and FT-ICR systems used in proteomics; also a partner of MRM Proteomics (VP on MRM's board) and provider of proteomics software such as ProteoWizard tools. Comparable as an incumbent that combines instruments, software and proteomics workflows.
• Charles River Laboratories: Large CRO offering a broad suite of discovery, safety and analytical services including proteomics and biomarker work for biopharma. Comparable as an enterprise-scale services alternative that biopharma customers may select over a specialised boutique like MRM Proteomics.
• Eurofins Scientific: Eurofins operates a global network of analytical and clinical testing laboratories including pharma services and bioanalytical offerings. Comparable as a large-scale alternative provider of analytical proteomics and metabolomics services to biopharma and academic clients.
• SCIEX (Danaher): SCIEX, a Danaher operating company, is a leading provider of triple quadrupole and QTOF mass spectrometers widely used in targeted proteomics and metabolomics. Comparable because MRM Proteomics kits are validated on SCIEX instruments and the company competes for the same research and clinical proteomics demand.
• Thermo Fisher Scientific: Thermo Fisher provides Orbitrap mass spectrometers, proteomics software (Proteome Discoverer) and large-scale proteomics services through its PPD/CRO business. A broad incumbent operating across the same instruments, kits and CRO services that MRM Proteomics addresses.

Direct peers

• Biognosys: Swiss targeted proteomics company offering DIA mass spectrometry–based protein quantification services and reagents (including the Spectronaut software). Directly comparable as a proteomics services and kits business serving biopharma with quantitative workflows.
• Promega Corporation: Promega supplies mass spec reagents, peptide standards and quantitative proteomics kits (e.g., MS-grade trypsin, UDP-Glo). Comparable in providing turnkey reagents and standards for quantitative MS-based proteomics workflows.
• Cell Signaling Technology: CST provides antibody-based proteomics reagents, including its CPTAC-aligned immunoassays and the ProteomeIFX pan-specific antibody platform. Competes with MRM Proteomics in quantitative protein analysis for translational and clinical research customers.

Emerging players

• Olink Holding (now part of Thermo Fisher): Olink's proximity extension assay (PEA) technology enables multiplexed protein biomarker measurement with high specificity using antibody-based dual recognition. Compares as an alternative protein quantitation platform competing for the same proteomics and biomarker customers MRM Proteomics serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MRMProteomics
• Facebookfacebook.com/MRMProteomics
• LinkedInlinkedin.com/company/mrm-proteomics-inc-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mrm Proteomics